NADH
enadoenaduenada
Reduced NAD+ form. Oral framework for fatigue, cognition, and Parkinson-disease contexts.
- Half-life
- 1 h
- Out of system
- ~5 h
- Route
- Oral
- Level
- Beginner
Very short-acting — protocols dose 1–2× a day. After the last dose, roughly 97% has cleared in ~5 h (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What NADH is used for
- Reduced NAD+ form — fatigue, focus, neurological contexts
- Oral route
How it's typically used
Typical: 5–20 mg oral daily.
What to watch for
- Oral bioavailability is debated
- Limited high-quality human data
- Effects are subtle
About Longevity
- What they are
- Compounds studied for cellular ageing — mitochondrial function, senescent-cell clearance, telomere and autophagy pathways.
- How they're run
- Mixed routes: some injected in short annual or biannual courses, others taken orally every day.
- What to watch
- Endpoints here are measured in decades, so nobody has human outcome data. Bloodwork and function markers are the only feedback you will get in a realistic timeframe.
Full guide
NADH: The Reduced Form, Oral Route, and What It Might Actually Help
A focused tracking guide for oral NADH supplementation in fatigue, cognition, and Parkinson disease contexts.
Other longevity
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.